Ventricular arrhythmias following balloon‐expandable transcatheter pulmonary valve replacement in the native right ventricular outflow tract

Ventricular arrhythmia incidence in children and adolescents undergoing transcatheter pulmonary valve replacement (TPVR) within the native right ventricular outflow tract (nRVOT) is unknown. We sought to describe the incidence, severity, and duration of ventricular arrhythmias and identify associated risk factors in this population.

[1]  P. Khairy,et al.  Ventricular Arrhythmias and Sudden Death Following Percutaneous Pulmonary Valve Implantation in Pediatric Patients , 2022, Pediatric Cardiology.

[2]  D. McElhinney,et al.  Ventricular arrhythmias following transcatheter pulmonary valve replacement with the harmony TPV25 device , 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[3]  S. Fichtlscherer,et al.  Percutaneous pulmonary valve implantation (PPVI) in non-obstructive right ventricular outflow tract: limitations and mid-term outcomes. , 2019, Translational pediatrics.

[4]  Joseph D. Kay,et al.  SAPIEN valve for percutaneous transcatheter pulmonary valve replacement without “pre‐stenting”: A multi‐institutional experience , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[5]  M. Fogel,et al.  3-Year Outcomes of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position From the COMPASSION Multicenter Clinical Trial. , 2018, JACC. Cardiovascular interventions.

[6]  D. McElhinney,et al.  Safety and Feasibility of Melody Transcatheter Pulmonary Valve Replacement in the Native Right Ventricular Outflow Tract: A Multicenter Pediatric Heart Network Scholar Study. , 2018, JACC. Cardiovascular interventions.

[7]  E. Tuzcu,et al.  Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial. , 2018, JACC. Cardiovascular interventions.

[8]  Jeremy P. Moore,et al.  Ventricular arrhythmia burden after transcatheter versus surgical pulmonary valve replacement , 2018, Heart.

[9]  W. Hellenbrand,et al.  Ventricular arrhythmias immediately following transcatheter pulmonary valve implantation: A cause for concern? , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[10]  J. Cheatham,et al.  Transcatheter pulmonary valve replacement using the melody valve for treatment of dysfunctional surgical bioprostheses: A multicenter study , 2017, The Journal of thoracic and cardiovascular surgery.

[11]  M. Mack,et al.  Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial , 2017, JAMA cardiology.

[12]  A. Qureshi,et al.  Percutaneous Pulmonary Valve Implantation-Associated Ventricular Tachycardia in Congenital Heart Disease. , 2016, Journal of interventional cardiology.

[13]  M. Fogel,et al.  Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: early phase 1 results from an international multicenter clinical trial. , 2011, Journal of the American College of Cardiology.

[14]  D. De Wolf,et al.  Early outcomes of percutaneous pulmonary valve implantation using the Edwards SAPIEN XT transcatheter heart valve system. , 2018, International journal of cardiology.

[15]  Z. Hijazi,et al.  Transcatheter pulmonary valve replacement: State of the art , 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.